Connect with us

Health

Accessibility Is Taking a Hit Across the Sciences

Published

on

Accessibility Is Taking a Hit Across the Sciences

Tyler Nelson, a postdoctoral researcher at the University of Florida, studies the neurobiology of pain, a choice partly motivated by his own frustrations with a neuromuscular disability. Last October, he applied for a grant at the National Institutes of Health that, if awarded, would support his dream of someday running his own lab.

But, earlier in February, he learned that his application, which took six months to pull together, was about to be thrown out.

The reason: Dr. Nelson had applied for a version of the award that supports researchers who are historically underrepresented in science, including people with disabilities. That funding avenue now violates President Trump’s executive order banning federal agencies from activities related to diversity, equity, inclusion and accessibility, or D.E.I.A.

Dr. Nelson was tipped off by an N.I.H. affiliate, but he has received no official notice about the situation. “I’ve tried to call probably 150 times,” he said. Unofficially, he learned that the agency was planning to pull his submission altogether rather than move it to the general award pool for consideration. This has happened with at least one other type of award offered by the agency, which did not respond to a request for comment.

Thanks to the tip, Dr. Nelson was able to withdraw his application and resubmit it to the general award pool before its deadline — but he is unsure if others were so lucky.

Advertisement

“What this does is discriminate against people who are underrepresented,” said an N.I.H. reviewer who asked to remain anonymous for fear of retaliation. The reviewer added that the evaluation criteria for the general and diversity award pools were the same, with no priority given to either pool. “I can’t stress enough,” the reviewer said, that an undeserving grant “is not going to get funded, whether it’s ‘diversity’ or not.”

According to Eve Hill, a civil rights lawyer in Washington, D.C., this may violate certain legal protections for people with disabilities, although there is no precedent in court.

“They’ve provided this category to overcome past discrimination,” she said. “By not then considering them in the general award, they are exacerbating that discrimination.”

The predicament is one of many ways that accessibility across the sciences is taking a hit from the D.E.I.A. shutdown. Federal agencies, once proponents for increasing opportunities for scientists with disabilities, are now ceasing programs geared toward that goal. Left uncertain is how funding for disability research — from designing accessible health services to building better prosthetics — will be affected by the order.

People with disabilities make up more than a quarter of the nation’s population and are considered to be the world’s largest minority. But experts say that, until recently, disability has largely been neglected in discussions about marginalized groups.

Advertisement

“Accessibility was always seen as an afterthought,” said Kim Knackstedt, a disability policy consultant in Washington, D.C. “Whether intentional or not, disability has been excluded from a lot of D.E.I. efforts.”

That extends to the sciences. The National Science Foundation reported that, in 2021, people with disabilities made up only 3 percent of the STEM work force. Only in 2023 did the N.I.H. designate people with disabilities as a community that experienced health disparities.

As the first director of disability policy in the Biden administration, Dr. Knackstedt led a push for accessibility to be at the forefront of diversity, equity and inclusion policy. One outcome of this effort was an executive order issued by President Biden that explicitly named accessibility as an area to strengthen in the federal work force.

“That was a win for many of us,” said Bonnielin Swenor, an epidemiologist who founded the Disability Health Research Center at Johns Hopkins University. Dr. Swenor, who experienced barriers pursuing a research career because of a visual impairment, added that it was disheartening “to have that progress not just stopped, but rolled back.”

Federal science agencies scrambled to comply with the reversal, leaving scientists and disability advocates apprehensive about the future of accessibility research. Earlier this month, the National Science Foundation began flagging grants that contained buzzwords commonly associated with D.E.I.A., including “disability” and “barrier.”

Advertisement

An N.S.F. program director, who asked not to be named out of fear of retaliation, said that there were “quite a few awards flagged for the word ‘disability,’” including projects to make driving and computing more accessible. The program director added that staff members were unsure if these research activities were banned by the executive order.

A spokesman for the N.S.F. did not answer questions sent by The New York Times regarding the eligibility of such awards.

Robert Gregg, an engineer at the University of Michigan who designs wearable robots for people with mobility impairments, said he had received notification from the N.S.F. to halt D.E.I.A. activities. But he interpreted that to mean supplemental programs aimed at increasing participation of underrepresented groups in science.

“Fundamental research in technology, like robotics and A.I. — my understanding is that that is still perfectly valid and can continue,” he said. But Dr. Gregg also runs clinical trials funded by the N.I.H., and he recently learned that the renewal process for this funding had effectively been frozen again.

Scientists with disabilities are also worried about what the clampdown on accessibility will mean for both their own careers and those of the next generation.

Advertisement

“Disabled people were barely being included,” said Alyssa Paparella, a graduate student at the Baylor College of Medicine who founded an online movement called #DisabledInSTEM. “Now there’s a huge fear of what’s going to be the future of all of us.”

A notice on the N.I.H. website encouraging participation of people with disabilities in the research enterprise has been removed, as has an N.S.F. webpage that listed funding opportunities for scientists with disabilities. Last month, the N.S.F. also indefinitely postponed an engineering workshop to better include people with autism and other neurocognitive differences in the work force.

In the geosciences, many degree programs require students to complete weekslong outdoor field camps that can be difficult to navigate with certain disabilities. This led Anita Marshall, a lecturer at the University of Florida, to found GeoSPACE, an N.S.F.-funded camp that incorporates modern technology and can be completed virtually.

She did not know if GeoSPACE would be able to continue. “This has really knocked me off my feet,” said Dr. Marshall, who described the project as her pride and joy. “I’m not sure what’s next.”

Doubts have sprung up for Dr. Nelson, too. Although he managed to salvage his application for N.I.H. funding, the change has pushed back any clarity about his future in research by at least five months.

Advertisement

“It’s a really dismal time in science for trainees,” he said. “I look at the last 15 years, like, ‘Why did I work this underpaid, high-stress job?’ Do I want to do this forever?”

Health

This could be why your weight-loss medication isn’t delivering results

Published

on

This could be why your weight-loss medication isn’t delivering results

NEWYou can now listen to Fox News articles!

The skyrocketing popularity of GLP-1 receptor agonists has transformed the weight-loss industry, but not all shots are created equal in terms of how they work.

A study published in Nature investigated how genes affect the success of modern weight-loss drugs — specifically, GLP-1s like semaglutide and tirzepatide.

In analyzing genetic data and self-reported weight loss from over 27,000 users, researchers pinpointed a specific variation in the GLP-1 receptor gene (GLP1R) that acts as a “booster” for the drug’s effectiveness.

POPULAR WEIGHT-LOSS MEDICATIONS LINKED TO HIDDEN SIDE EFFECTS, STUDY FINDS

Advertisement

Individuals carrying one copy of this variant lost an average of 1.6 pounds more than those without it, according to the findings.

This suggests that genetic testing could eventually help doctors steer sensitive patients toward medications they are more likely to tolerate.

Individuals carrying one copy of a specific genetic variant lost an average of 1.6 pounds more than those without it. (iStock)

“We believe these reports are a step forward in meeting an unmet need for a more informed and personalized approach to weight management,” said study co-author Noura Abul-Husn, chief medical officer at the 23andMe Research Institute in California, in a press release.

While this genetic “boost” is measurable, it remains relatively modest when compared to the total average weight loss of 24 pounds observed across the study population, the researchers noted.

Advertisement

SHOULD YOU MICRODOSE OZEMPIC? EXPERTS ARE SPLIT ON RISKS VS BENEFITS

Beyond genetics, other factors such as age, sex and specific medications remain much stronger predictors of success.

For instance, the study found that women generally saw a higher body mass index (BMI) reduction (12.2%) compared to men (10.0%).

Traditional factors such as age, sex and specific medications remain much stronger predictors of success. (iStock)

The study may also reveal why certain patients experience stomach issues. Scientists identified a different genetic variant that was linked to increased reports of nausea and vomiting.

Advertisement

The presence of this side effect did not impact the drug’s effectiveness, however. Patients with variants in the GLP1R and GIPR genes lost just as much weight as those without it; they simply felt more sick during the process, the study found.

WEIGHT-LOSS MEDICATIONS COULD IMPACT SEXUAL HEALTH IN UNEXPECTED WAYS

“GLP-1 treatment decisions are complex, and having access to clinical expertise to help contextualize your genetic results alongside your full health picture is exactly the kind of guidance this report is designed to support,” said Abul-Husn.

Patients with the variant lost just as much weight as those without it; they simply felt more sick during the process, the study found. (iStock)

Dr. Peter Balazs, MD, a hormone and weight-loss specialist serving the New York and New Jersey area, was not involved in the study but reiterated the role of the genetic variants in treatment response and side effects.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

“Notably, there appears to be a drug-specific effect: The GIPR variant associated with these side effects is observed with tirzepatide, but not with semaglutide,” he told Fox News Digital.

Balazs said he was surprised by the extremely wide nausea risk range (5%–78%). “Additionally, the drug-specific genetic dissociation was unexpected,” he added.

Study limitations

The data relied on participants reporting their own weight, which could be subject to bias.

“The data is self-reported and not medically verified, which may affect its reliability firstly,” Balazs told Fox News Digital. “It also does not account for key treatment variables, such as titration, discontinuation or dosing schedules.”

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The 23andMe participant pool may not reflect a diverse, real-world population, he added.

“The study also lacks data on important clinical endpoints, such as diabetes progression, and severe adverse effects, such as gastroparesis or pancreatitis,” Balazs pointed out. “Many of its findings also have not been supported by more clinically and statistically robust studies.”

Patients with the variant lost just as much weight as those without it; they simply felt more sick during the process, the study found. (iStock)

For example, a sub-study comparing these reports to objective iPhone health data suggested that participants might over-report their progress. While users reported an 11.8% loss, electronic data in that subset showed a 5.8% loss.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

As an observational study rather than a controlled clinical trial, it could not definitively prove that the genetic variants caused the difference in weight loss, only that they are associated with it, the researchers noted.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“I think this article is interesting, raising the possibility of genetic factors, and the use of genetic testing incorporated into further decision-making when picking weight-loss medications,” Balazs said. “However, I would be careful to draw conclusions solely based on this study.”

Advertisement
Continue Reading

Health

Considering Phentermine for Weight Loss? Who Should Take It Over a GLP-1

Published

on

Considering Phentermine for Weight Loss? Who Should Take It Over a GLP-1


Advertisement





Phentermine for Weight Loss Curbs Cravings and Speeds Results




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Sleeping without a pillow could have surprising health benefit, study suggests

Published

on

Sleeping without a pillow could have surprising health benefit, study suggests

NEWYou can now listen to Fox News articles!

Sleeping with, or without, a pillow may have a sneaky impact on your health.

New research suggests that skipping the pillow could help prevent the development of glaucoma, an eye disease that damages the optic nerve and can cause vision loss or blindness.

Glaucoma can be caused by elevated eye pressure, thinning of the optic nerve or fluid buildup, according to the Glaucoma Research Foundation.

SLEEP PATTERNS COULD PREDICT RISK FOR DEMENTIA, CANCER AND STROKE, STUDY SUGGESTS

Advertisement

The study, published in the British Journal of Ophthalmology, found that eye pressure was higher in glaucoma patients who slept with two pillows compared to lying flat. Blood flow to the eye decreased in the high-pillow position.

This may occur due to the neck bending forward, compressing the veins, the authors suggested. Glaucoma patients may benefit from avoiding sleep postures that put the neck in this position, they concluded.

New research suggests that skipping the pillow could help prevent the development of glaucoma, an eye disease that damages the optic nerve and can cause vision loss or blindness. (iStock)

Dr. William Lu, medical director at Dreem Health, who was not involved in the study, called these findings “interesting and important.”

“It highlights how something as simple as sleep posture can influence intra-ocular pressure in people with glaucoma,” the San Francisco-based expert told Fox News Digital.

Advertisement

COMMON SLEEP AID COULD BE QUIETLY INTERFERING WITH YOUR REST, STUDY SUGGESTS

“That said, this is still early research, and it doesn’t mean pillows are inherently harmful – it’s more about how they’re used and the degree of elevation.”

The key takeaway is “balance and personalization,” Lu said. Most people don’t need to eliminate pillows, but should avoid “extreme positions,” such as sleeping with the head sharply elevated or with the neck bent at an awkward angle, he noted.

Most people don’t need to eliminate pillows, but should avoid “extreme positions,” such as sleeping with the head sharply elevated or with the neck bent at an awkward angle, an expert noted. (iStock)

Sleeping without a pillow can help promote a more neutral neck alignment for some people, especially those who sleep on their backs, according to Lu.

Advertisement

“That can reduce strain on the cervical spine and may improve comfort or reduce morning stiffness,” he said. “In certain cases, it may also reduce pressure points that come from overly thick or unsupportive pillows.”

CLICK HERE FOR MORE HEALTH STORIES

Going pillow-free isn’t ideal for side sleepers, who often need a pillow to keep the head aligned with the spine, Lu added.

“Without one, the neck can tilt downward and create strain over time,” he said. “For others, skipping a pillow can worsen snoring or airway positioning, and people with existing neck or shoulder issues may actually feel worse without proper support.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

For those who have glaucoma or are at higher risk, Lu recommends discussing sleep posture with a healthcare provider and aiming for a position that keeps the head and neck aligned without excessive elevation.

“Small adjustments in sleep setup can be a simple but meaningful way to support overall health,” he said.

Side sleepers should sleep with a pillow to support posture, experts recommend. (iStock)

In a separate interview with Fox News Digital, Dr. Saema Tahir, a board-certified sleep disorder specialist in New York City, said these findings align with prior research showing that “how you elevate your head matters.”

“Elevating the head of the bed itself can reduce eye pressure, but using multiple pillows may not have the same effect – and could even be counterproductive in some cases,” she said.

Advertisement

Tahir stressed that there is “very limited high-quality evidence” showing health benefits from sleeping without a pillow.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“What matters most is maintaining proper alignment of the cervical spine, and that varies from person to person,” she said. “Without adequate support, especially for side sleepers, the neck can fall out of alignment.”

This can manifest as neck pain and stiffness, morning headaches, or shoulder and arm discomfort.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“So, for many people, especially side sleepers, skipping a pillow can actually make sleep quality worse,” the expert said.

“For those with glaucoma or at risk should avoid sleeping face-down with pressure on the eyes and should be cautious with very high or stacked pillows … Be mindful of side sleeping, as the lower eye can experience higher pressure.”

Advertisement
Continue Reading

Trending